Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Long-Term Deferred Tax (2017 - 2025)

Historic Long-Term Deferred Tax for Cross Country Healthcare (CCRN) over the last 12 years, with Q3 2025 value amounting to $9.5 million.

  • Cross Country Healthcare's Long-Term Deferred Tax rose 466.92% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 466.92%. This contributed to the annual value of $8.1 million for FY2024, which is 3554.11% up from last year.
  • As of Q3 2025, Cross Country Healthcare's Long-Term Deferred Tax stood at $9.5 million, which was up 466.92% from $8.2 million recorded in Q2 2025.
  • Cross Country Healthcare's Long-Term Deferred Tax's 5-year high stood at $11.5 million during Q4 2021, with a 5-year trough of $6.0 million in Q4 2023.
  • In the last 5 years, Cross Country Healthcare's Long-Term Deferred Tax had a median value of $8.1 million in 2024 and averaged $8.3 million.
  • In the last 5 years, Cross Country Healthcare's Long-Term Deferred Tax plummeted by 3824.73% in 2022 and then skyrocketed by 3832.26% in 2024.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Long-Term Deferred Tax stood at $11.5 million in 2021, then crashed by 38.25% to $7.1 million in 2022, then dropped by 15.99% to $6.0 million in 2023, then skyrocketed by 35.54% to $8.1 million in 2024, then rose by 16.73% to $9.5 million in 2025.
  • Its last three reported values are $9.5 million in Q3 2025, $8.2 million for Q2 2025, and $8.8 million during Q1 2025.